Anthony Prentice

Chief Product Officer, GeneDx Holdings Corp.

Companies

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

As of each latest filing. The line shows shares held over time.

Jul 26, 2022Sold 1,698 shares at $1.47 of GeneDx Holdings Corp.²
Jul 25, 2022Exercised options 3,940 shares of GeneDx Holdings Corp.²
Jul 5, 2022Sold 1,828 shares at $1.32 of GeneDx Holdings Corp.³
Jul 1, 2022Exercised options 4,576 shares of GeneDx Holdings Corp.³
Apr 28, 2022Sold 1,691 shares at $2.18 of GeneDx Holdings Corp.⁴
Apr 25, 2022Exercised options 3,940 shares of GeneDx Holdings Corp.⁵
Jan 28, 2022Sold 2,021 shares at $2.84 of GeneDx Holdings Corp.⁶
Jan 25, 2022Exercised options 3,940 shares of GeneDx Holdings Corp.⁷
Dec 1, 2021Shares withheld for tax 2,885 shares at $5.52 of GeneDx Holdings Corp.⁸
Dec 1, 2021Granted 6,257 shares at $6.05 of GeneDx Holdings Corp.⁸
Oct 25, 2021Sold 1,620 shares at $8.09 of GeneDx Holdings Corp.⁹
Oct 25, 2021Exercised options 3,940 shares of GeneDx Holdings Corp.⁹

The numbers on this page point here. Each one links to the record it came from.